Looking for ILS? We've moved to our new website. Some users may experience temporary access delays during the transition. We appreciate your patience as we complete this update.
Share to
  • Email
  • Facebook
  • X
  • Bluesky
  • Instagram
  • LinkedIn
Share to
  • Email
  • Facebook
  • X
  • Bluesky
  • Instagram
  • LinkedIn
Back to Test Catalogue
Test ID: CXCL9 P

CXCL 9/MIG, Plasma

Test Overview

Clinical Utility

Results should be interpreted in the context of the clinical presentation, therapeutic intervention, and additional laboratory data. Assay performance has not been validated in the context of treatment monitoring following administration of cytokine-blocking therapies; interpret results in this context with caution.

Method

Fluorescence immunoassay (FIA)

Analytical Platform

Proteinsimple ELLA<br>This analysis is performed at Hospital for Sick Children, Toronto, ON, CA

Result Included

CXCL 9/MIG;
This test is available as an individual test order or it may be ordered as part of a three-test profile Cytokine Panel 2 (TNFA, CXCL9, IFNG), Plasma.. The price for the three-test profile is less than the combined total price of any two or three of these tests ordered individually.

Aliases/Synonyms

MIG1; Monokine Induced by Gamma Interferon

Specimen

Specimen Type

Plasma (EDTA)

Containers

Collection Containers

Lavender top (EDTA)

Volume

Sample Volume

0.5 mL x 2

Minimum Volume

0.25 mL x 2

Collection & Handling

Handling Information

Separate within 30 minutes of collection. Centrifuge for 15 minutes at 1000 RCF. Prepare two 0.5 mL aliquots (min 2 x 0.25 mL). Store and ship frozen.

Additional Information

Avoid freeze-thaw cycles

Stability

Ambient
Unacceptable

Avoid freeze-thaw cycles

Rejection Criteria

Criteria Specification
Hemolysis Gross
Lipemia Gross

Performance & Interpretation

Turnaround Time

14 days

Results

Name
Units
Reference Range
Conversion
  1. CXCL 9/MIG
    pg/mL
    ≤657

    Comment

    Results should be interpreted in the context of the clinical presentation, therapeutic intervention, and additional laboratory data. Assay performance has not been validated in the context of treatment monitoring following administration of cytokine-blocking therapies; interpret results in this context with caution.

Referral Location

Canada

Interface & Setup

HL7 Interface Codes

Order Code Result Name Result Codes Units
CXCL9 P CXCL9 64154 pg/mL
CXCL9 Comment 64467

Test Version

Last Updated

2022-06-22